Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Debt / NOTE 1.750% 6/1
-
Market price (% of par)
-
83.24%
-
Total 13F principal
-
$331,259,500
-
Principal change
-
+$4,623,000
-
Total reported market value
-
$275,710,276
-
Number of holders
-
37
-
Value change
-
+$3,758,460
-
Number of buys
-
14
-
Number of sells
-
14
Institutional Holders of ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 as of Q4 2018
As of 31 Dec 2018,
ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 was held by
37 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$331,259,500
in principal (par value) of the bond.
The largest 10 bondholders included
Partner Fund Management, L.P., CITADEL ADVISORS LLC, CANYON CAPITAL ADVISORS LLC, D. E. Shaw & Co., Inc., CNH PARTNERS LLC, Jefferies Group LLC, CAPSTONE INVESTMENT ADVISORS, LLC, DLD Asset Management, LP, UBS OCONNOR LLC, and CREDIT SUISSE AG/.
This page lists
37
institutional bondholders reporting positions
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.